Barclays PLC reaffirmed their equal weight rating on shares of Humana Inc. (NYSE:HUM) in a report issued on Friday morning. They currently have a $191.00 price objective on the insurance provider’s stock.
A number of other equities analysts also recently weighed in on HUM. Leerink Swann reaffirmed an outperform rating on shares of Humana in a research note on Tuesday, June 21st. Wolfe Research started coverage on shares of Humana in a research note on Tuesday, June 28th. They issued a market perform rating and a $244.00 target price on the stock. Credit Suisse Group AG reissued a hold rating on shares of Humana in a research note on Tuesday, June 28th. JPMorgan Chase & Co. downgraded shares of Humana from an overweight rating to a neutral rating and dropped their price target for the stock from $196.00 to $150.00 in a research note on Friday, July 8th. Finally, Cantor Fitzgerald reaffirmed a buy rating on shares of Humana in a research note on Saturday, July 9th. Seven analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Humana currently has an average rating of Buy and an average target price of $200.50.
Humana (NYSE:HUM) traded down 0.39% during trading on Friday, hitting $170.15. 143,755 shares of the company’s stock traded hands. Humana has a 12-month low of $150.00 and a 12-month high of $191.65. The stock has a market cap of $25.36 billion, a P/E ratio of 26.14 and a beta of 0.90. The firm’s 50-day moving average price is $175.94 and its 200 day moving average price is $175.74.
Humana (NYSE:HUM) last announced its earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.23 by $0.07. Humana had a net margin of 1.76% and a return on equity of 11.11%. The firm had revenue of $14 billion for the quarter, compared to analyst estimates of $13.59 billion. During the same quarter last year, the business earned $1.67 earnings per share. Humana’s revenue was up 2.0% compared to the same quarter last year. Analysts anticipate that Humana will post $9.24 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Thursday, October 13th will be given a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a yield of 0.68%. The ex-dividend date is Tuesday, October 11th. Humana’s payout ratio is presently 18.18%.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Virginia Retirement System acquired a new stake in Humana during the first quarter valued at approximately $440,000. NN Investment Partners Holdings N.V. purchased a new stake in shares of Humana during the first quarter worth $3,104,000. Bessemer Group Inc. boosted its stake in shares of Humana by 392.6% in the first quarter. Bessemer Group Inc. now owns 1,000 shares of the insurance provider’s stock worth $183,000 after buying an additional 797 shares during the last quarter. Spark Investment Management LLC purchased a new stake in shares of Humana during the first quarter worth $274,000. Finally, Aviva PLC boosted its stake in shares of Humana by 1.9% in the first quarter. Aviva PLC now owns 86,580 shares of the insurance provider’s stock worth $15,840,000 after buying an additional 1,632 shares during the last quarter. 93.27% of the stock is currently owned by hedge funds and other institutional investors.
Humana Company Profile